Category: Moderna
Germany: Fourth Covid vaccination offered for “a quieter and symptom-free summer”
Germany’s health minister Karl Lauterbach has announced plans to offer every citizen a fourth Covid vaccination so that they can have “a quieter and symptom-free summer”. More...
Israel: Fifth Covid-19 vaccination under consideration
A fifth round of Covid vaccinations is under consideration in Israel, according to the Jerusalem Post. More...
Moderna looks at producing a Monkeypox vaccine
Moderna is considering turning its mRNA vaccine platform towards finding a vaccine to defend against Monkeypox, according to a recent tweet by the company. More...
Preprint: Enhanced Fusogenicity of BA.4, BA.5 and BA.2.12.1
“We found that the new Omicron subvariants BA.4/5 and BA.2.12.1 were more resistant to neutralization by mRNA-vaccinated and boosted health care worker sera and Omicron-BA.1-wave patient sera than were the BA.1 and BA.2 variants.” More...
Preprint: SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis
“Here, we report the case of a 52-year-old male, presenting with bimodal episodes of acute hepatitis, each occurring 2-3 weeks after BNT162b2 mRNA vaccination and sought to identify the underlying immune correlates. More...
Spain: Fully boosted healthcare worker reinfected with SARs-CoV-2 after just 20 days
A fully boosted 31-year-old Spanish woman has contracted two different SARS-CoV-2 variants within three weeks. More...
EMA: “Too early to consider using a fourth dose of mRNA COVID-19 vaccines”
The European Centre for Disease Prevention and Control (ECDC) and EMA’s COVID-19 task force (ETF) have concluded that it is too early to consider using a fourth dose of mRNA COVID-19 vaccines (Pfizer’s Comirnaty and Moderna’s Spikevax) in the general population. More...
UK: Fifth Covid-19 jab in two years for the over 50’s planned
The UK Health Secretary has suggested that a fifth dose of a Covid-19 may be needed in the autumn of 2022. More...
Preprint: Prior natural infection compared to mRNA vaccination for SARS-CoV-2
Natural infection was associated with stronger and more durable protection against infection, regardless of the variant, than mRNA primary-series vaccination. More...
Pfizer and Moderna: Fourth shot of COVID vaccine on the way
A fourth dose of Pfizer’s COVID-19 vaccine will be necessary in order to maintain manageable levels of hospitalizations and mild infections, CEO Albert Bourla said yesterday. More...